[PANAMY] QoQ Cumulative Quarter Result on 30-Jun-2020 [#1]

Stock
[PANAMY] PANASONIC MANUFACTURING MSIA
Announcement Date
21-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2021
Quarter
30-Jun-2020 [#1]
Profit Trend
QoQ- -102.19%
YoY- -109.45%
Quarter Report
Latest QR
Upcoming QR
PANAMY's Result
PANAMY's Financial Summary
View:
Show?
Cumulative Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 974,558 708,997 448,047 154,083 1,051,980 847,330 579,987 41.29%
PBT 135,151 82,150 43,858 -3,759 141,227 107,317 75,173 47.80%
Tax -18,697 -11,267 -6,379 1,199 -24,238 -20,627 -17,295 5.32%
NP 116,454 70,883 37,479 -2,560 116,989 86,690 57,878 59.30%
-
NP to SH 116,454 70,883 37,479 -2,560 116,989 86,690 57,878 59.30%
-
Tax Rate 13.83% 13.72% 14.54% - 17.16% 19.22% 23.01% -
Total Cost 858,104 638,114 410,568 156,643 934,991 760,640 522,109 39.22%
-
Net Worth 812,781 776,333 742,923 813,996 816,426 795,165 766,614 3.97%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div 99,015 9,111 9,111 - 120,277 9,111 9,111 389.92%
Div Payout % 85.03% 12.85% 24.31% - 102.81% 10.51% 15.74% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 812,781 776,333 742,923 813,996 816,426 795,165 766,614 3.97%
NOSH 60,746 60,746 60,746 60,746 60,746 60,746 60,746 0.00%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 11.95% 10.00% 8.36% -1.66% 11.12% 10.23% 9.98% -
ROE 14.33% 9.13% 5.04% -0.31% 14.33% 10.90% 7.55% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 1,604.32 1,167.15 737.57 253.65 1,731.77 1,394.87 954.77 41.29%
EPS 192.00 117.00 62.00 -4.00 193.00 143.00 95.00 59.78%
DPS 163.00 15.00 15.00 0.00 198.00 15.00 15.00 389.89%
NAPS 13.38 12.78 12.23 13.40 13.44 13.09 12.62 3.97%
Adjusted Per Share Value based on latest NOSH - 60,746
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 1,580.15 1,149.57 726.46 249.83 1,705.68 1,373.86 940.39 41.29%
EPS 188.82 114.93 60.77 -4.15 189.69 140.56 93.84 59.31%
DPS 160.54 14.77 14.77 0.00 195.02 14.77 14.77 389.97%
NAPS 13.1785 12.5875 12.0458 13.1982 13.2376 12.8928 12.4299 3.97%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 31.00 30.80 28.42 30.00 26.88 37.00 37.80 -
P/RPS 1.93 2.64 3.85 11.83 1.55 2.65 3.96 -38.04%
P/EPS 16.17 26.40 46.06 -711.87 13.96 25.93 39.67 -44.99%
EY 6.18 3.79 2.17 -0.14 7.16 3.86 2.52 81.75%
DY 5.26 0.49 0.53 0.00 7.37 0.41 0.40 456.24%
P/NAPS 2.32 2.41 2.32 2.24 2.00 2.83 3.00 -15.73%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 28/05/21 22/02/21 30/11/20 21/08/20 06/07/20 26/02/20 25/11/19 -
Price 31.60 30.06 31.06 31.54 30.40 33.90 37.14 -
P/RPS 1.97 2.58 4.21 12.43 1.76 2.43 3.89 -36.43%
P/EPS 16.48 25.76 50.34 -748.41 15.79 23.75 38.98 -43.63%
EY 6.07 3.88 1.99 -0.13 6.34 4.21 2.57 77.25%
DY 5.16 0.50 0.48 0.00 6.51 0.44 0.40 449.18%
P/NAPS 2.36 2.35 2.54 2.35 2.26 2.59 2.94 -13.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment